|Bid||17.35 x 100|
|Ask||17.40 x 1500|
|Day's Range||17.02 - 17.33|
|52 Week Range||15.22 - 51.51|
|PE Ratio (TTM)||-2.81|
|Dividend & Yield||1.10 (6.10%)|
|1y Target Est||N/A|
A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction have demanded fresh documents from drugmakers and distributors.
The generic drugmaker said the changes will give it “greater flexibility.”
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is off more than 50% so far this year. This is one of the leading generic drug producers in the world. Unfortunately, U.S. courts changed the dynamic by allowing more generics competition sooner than TEVA counted on.